IGFBP6
Reaktivität: Human
WB, IHC, ICC
Wirt: Kaninchen
Polyclonal
unconjugated
Applikationshinweise
ELISA (1:32000) Western Blot (0.5-1.5 μg/mL) The optimal working dilution should be determined by the end user.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
0.5 mg/mL
Buffer
In Tris saline, pH 7.3 (0.5 % BSA, 0.02 % sodium azide)
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20°C. Aliquot to avoid repeated freezing and thawing.
Cheung, Vesey, Cotterill, Douglas, Gobe, Nicol, Johnson: "Altered messenger RNA and protein expressions for insulin-like growth factor family members in clear cell and papillary renal cell carcinomas." in: International journal of urology : official journal of the Japanese Urological Association, Vol. 12, Issue 1, pp. 17-28, (2005) (PubMed).
Target
IGFBP6
(Insulin-Like Growth Factor Binding Protein 6 (IGFBP6))